Loss of CDK4/6 cell cycle regulation occurs in 20–35% of breast cancer and promotes CDK2 activity, driving the cell cycle progression without the need of CDK4/6 (Vidula and Rugo, 2016). This evidence concerns the gene CDK4 and breast cancer.